Low-molecular-weight heparin or warfarin for anticoagulation in pregnant women with mechanical heart valves: what are the risks? A retrospective observational study
Version of Record online: 9 MAY 2012
© 2012 The Authors BJOG An International Journal of Obstetrics and Gynaecology © 2012 RCOG
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 119, Issue 8, pages 1008–1013, July 2012
How to Cite
Basude, S., Hein, C., Curtis, S., Clark, A. and Trinder, J. (2012), Low-molecular-weight heparin or warfarin for anticoagulation in pregnant women with mechanical heart valves: what are the risks? A retrospective observational study. BJOG: An International Journal of Obstetrics & Gynaecology, 119: 1008–1013. doi: 10.1111/j.1471-0528.2012.03359.x
- Issue online: 17 JUN 2012
- Version of Record online: 9 MAY 2012
- Accepted 18 March 2012.
Table S1. Maternal characteristics in the Warfarin, Combination and the LMWHa (Low molecular weight heparin and aspirin) groups. All identified risk factors mentioned in respective columns, where not mentioned no risk factors were identified.
|BJO_3359_sm_TableS1.pdf||41K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.